Novartis Ag (NVS) Retained Earnings (2009 - 2025)

Novartis Ag (NVS) has 11 years of Retained Earnings data on file, last reported at $45.4 billion in Q4 2025.

• Quarterly Retained Earnings rose 4.87% year-over-year to $45.4 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $45.4 billion (up 4.87% YoY) and the FY2025 annual result came in at $45.4 billion, up 4.87% from the prior year.
• Retained Earnings grew to $45.4 billion in Q4 2025 per NVS's latest filing, from $41.3 billion in the prior quarter.
• The five-year high for Retained Earnings was $66.8 billion in Q4 2021, with the low at $41.0 billion in Q2 2024.
• Average Retained Earnings over 5 years is $50.9 billion, with a median of $48.5 billion recorded in 2023.
• Year-over-year, Retained Earnings gained 19.85% in 2021 and dropped 21.63% in 2023.
• Novartis Ag's Retained Earnings stood at $66.8 billion in 2021, then retreated by 12.36% to $58.5 billion in 2022, then retreated by 21.63% to $45.9 billion in 2023, then retreated by 5.62% to $43.3 billion in 2024, then gained by 4.87% to $45.4 billion in 2025.
• Business Quant data shows NVS's Retained Earnings at $45.4 billion in Q4 2025, $41.3 billion in Q2 2025, and $43.3 billion in Q4 2024.